CAR T-cell therapies specialist CARsgen Therapeutics (Shanghai) has announced the completion of a 37,000-ft2 facility for clinical and early-stage commercial manufacturing after 12 months of construction. The company enlisted the help of CRB (St. Louis) in building the cGMP manufacturing facility located within the Research Triangle Park In Durham, North Carolina. CRB is an engineering,…